(ADX) Adams Diversified Equity - Overview
Fund: Equities, Large-Cap, Blend, Diversified, Index
Dividends
| Dividend Yield | 8.62% |
| Yield on Cost 5y | 15.07% |
| Yield CAGR 5y | 70.29% |
| Payout Consistency | 83.4% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 16.2% |
| Relative Tail Risk | 4.11% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.94 |
| Alpha | 7.90 |
| Character TTM | |
|---|---|
| Beta | 0.867 |
| Beta Downside | 0.866 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.29% |
| CAGR/Max DD | 1.43 |
Description: ADX Adams Diversified Equity January 13, 2026
Adams Diversified Equity Closed Fund (NYSE: ADX) is a U.S.-based closed-end fund that follows a large-cap growth investment style, targeting companies with strong earnings momentum and scalable business models.
Key performance indicators to watch include its 30-day net asset value (NAV) premium/discount, which has recently narrowed to around 3% below NAV, and its trailing 12-month total return, which has outperformed the S&P 500 by roughly 2.5 percentage points.
The fund’s performance is closely tied to macro-level drivers such as U.S. consumer spending trends and the Federal Reserve’s interest-rate policy, both of which influence the valuation of growth stocks in sectors like technology and healthcare.
Sector exposure is heavily weighted toward information technology (≈45% of assets) and health care (≈20%), reflecting the fund’s emphasis on firms benefiting from digital transformation and aging demographics.
For a deeper, data-driven analysis of ADX’s valuation metrics and risk profile, you might explore the fund’s profile on ValueRay.
What is the price of ADX shares?
Over the past week, the price has changed by -1.37%, over one month by +0.50%, over three months by +3.77% and over the past year by +21.54%.
Is ADX a buy, sell or hold?
What are the forecasts/targets for the ADX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 30.7 | 33% |
ADX Fundamental Data Overview February 09, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.09b USD (2.09b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.09b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.09b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.11% (E(2.09b)/V(2.09b) * Re(9.11%) + (debt-free company))
Discount Rate = 9.11% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)